Organ failure and tight glycemic control in the SPRINT study

IntroductionIntensive care unit mortality is strongly associated with organ failure rate and severity. The sequential organ failure assessment (SOFA) score is used to evaluate the impact of a successful tight glycemic control (TGC) intervention (SPRINT) on organ failure, morbidity, and thus mortality.MethodsA retrospective analysis of 371 patients (3,356 days) on SPRINT (August 2005 - April 2007) and 413 retrospective patients (3,211 days) from two years prior, matched by Acute Physiology and Chronic Health Evaluation (APACHE) III. SOFA is calculated daily for each patient. The effect of the SPRINT TGC intervention is assessed by comparing the percentage of patients with SOFA ≤5 each day and its trends over time and cohort/group. Organ-failure free days (all SOFA components ≤2) and number of organ failures (SOFA components >2) are also compared. Cumulative time in 4.0 to 7.0 mmol/L band (cTIB) was evaluated daily to link tightness and consistency of TGC (cTIB ≥0.5) to SOFA ≤5 using conditional and joint probabilities.ResultsAdmission and maximum SOFA scores were similar (P = 0.20; P = 0.76), with similar time to maximum (median: one day; IQR: [1, 3] days; P = 0.99). Median length of stay was similar (4.1 days SPRINT and 3.8 days Pre-SPRINT; P = 0.94). The percentage of patients with SOFA ≤5 is different over the first 14 days (P = 0.016), rising to approximately 75% for Pre-SPRINT and approximately 85% for SPRINT, with clear separation after two days. Organ-failure-free days were different (SPRINT = 41.6%; Pre-SPRINT = 36.5%; P < 0.0001) as were the percent of total possible organ failures (SPRINT = 16.0%; Pre-SPRINT = 19.0%; P < 0.0001). By Day 3 over 90% of SPRINT patients had cTIB ≥0.5 (37% Pre-SPRINT) reaching 100% by Day 7 (50% Pre-SPRINT). Conditional and joint probabilities indicate tighter, more consistent TGC under SPRINT (cTIB ≥0.5) increased the likelihood SOFA ≤5.ConclusionsSPRINT TGC resolved organ failure faster, and for more patients, from similar admission and maximum SOFA scores, than conventional control. These reductions mirror the reduced mortality with SPRINT. The cTIB ≥0.5 metric provides a first benchmark linking TGC quality to organ failure. These results support other physiological and clinical results indicating the role tight, consistent TGC can play in reducing organ failure, morbidity and mortality, and should be validated on data from randomised trials.

[1]  T. Walsh,et al.  The impact of organ failures and their relationship with outcome in intensive care: analysis of a prospective multicentre database of adult admissions , 2006, Anaesthesia.

[2]  G. Van den Berghe.  How does blood glucose control with insulin save lives in intensive care? , 2004, The Journal of clinical investigation.

[3]  Christian Trautwein,et al.  Serum resistin levels in critically ill patients are associated with inflammation, organ dysfunction and metabolism and may predict survival of non-septic patients , 2009, Critical care.

[4]  S E Kahn,et al.  The effect of insulin dose on the measurement of insulin sensitivity by the minimal model technique. Evidence for saturable insulin transport in humans. , 1996, The Journal of clinical investigation.

[5]  N. Maglaveras,et al.  Investigation of altered heart rate variability, nonlinear properties of heart rate signals, and organ dysfunction longitudinally over time in intensive care unit patients. , 2006, Journal of critical care.

[6]  Thomas Lotz,et al.  A pilot study of the SPRINT protocol for tight glycemic control in critically Ill patients. , 2006, Diabetes technology & therapeutics.

[7]  Christopher E. Hann,et al.  Impact of insulin-stimulated glucose removal saturation on dynamic modelling and control of hyperglycaemia , 2005, Int. J. Intell. Syst. Technol. Appl..

[8]  Ben Zarzaur,et al.  Performance of a dose-defining insulin infusion protocol among trauma service intensive care unit admissions. , 2006, Diabetes technology & therapeutics.

[9]  B. Bistrian,et al.  Intensive insulin therapy in critically ill patients. , 2002, The New England journal of medicine.

[10]  A. Groeneveld,et al.  Age, chronic disease, sepsis, organ system failure, and mortality in a medical intensive care unit. , 1990, Critical care medicine.

[11]  G. Van den Berghe,et al.  Metabolic, endocrine, and immune effects of stress hyperglycemia in a rabbit model of prolonged critical illness. , 2003, Endocrinology.

[12]  G. Van den Berghe,et al.  Intensive insulin therapy in the medical ICU. , 2006, The New England journal of medicine.

[13]  Deborah J. Cook,et al.  Intensive insulin therapy and mortality among critically ill patients: a meta-analysis including NICE-SUGAR study data , 2009, Canadian Medical Association Journal.

[14]  C. Sprung,et al.  The use of maximum SOFA score to quantify organ dysfunction/failure in intensive care. Results of a prospective, multicentre study , 1999, Intensive Care Medicine.

[15]  Rolf Rossaint,et al.  Intensive insulin therapy and pentastarch resuscitation in severe sepsis. , 2008, The New England journal of medicine.

[16]  G. Van den Berghe,et al.  Clinical benefits of tight glycaemic control: focus on the intensive care unit. , 2009, Best practice & research. Clinical anaesthesiology.

[17]  S. Kromhout-Schiro,et al.  Glasgow Coma Scale score, mortality, and functional outcome in head-injured patients. , 2004, The Journal of trauma.

[18]  G. Van den Berghe,et al.  Glycemic control modulates arginine and asymmetrical-dimethylarginine levels during critical illness by preserving dimethylarginine-dimethylaminohydrolase activity. , 2008, Endocrinology.

[19]  M. Brownlee.  Biochemistry and molecular cell biology of diabetic complications , 2001, Nature.

[20]  Jaap E Tulleken,et al.  Towards a feasible algorithm for tight glycaemic control in critically ill patients: a systematic review of the literature , 2006, Critical care.

[21]  Christopher E. Hann,et al.  Stochastic modelling of insulin sensitivity and adaptive glycemic control for critical care , 2008, Comput. Methods Programs Biomed..

[22]  A Mari,et al.  Dose-response characteristics of insulin action on glucose metabolism: a non-steady-state approach. , 2000, American journal of physiology. Endocrinology and metabolism.

[23]  T Lotz,et al.  A novel, model-based insulin and nutrition delivery controller for glycemic regulation in critically ill patients. , 2006, Diabetes technology & therapeutics.

[24]  Ning Li,et al.  [Influence and mechanism of a tight control of blood glucose by intensive insulin therapy on human sepsis]. , 2005, Zhonghua wai ke za zhi [Chinese journal of surgery].

[25]  N F de Keizer,et al.  Reliability and accuracy of Sequential Organ Failure Assessment (SOFA) scoring , 2005, Critical care medicine.

[26]  Rinaldo Bellomo,et al.  Variability of Blood Glucose Concentration and Short-term Mortality in Critically Ill Patients , 2006, Anesthesiology.

[27]  Ilse Vanhorebeek,et al.  Intensive insulin therapy protects the endothelium of critically ill patients. , 2005, The Journal of clinical investigation.

[28]  A. Aljada,et al.  Insulin infusion in acute illness. , 2005, The Journal of clinical investigation.

[29]  G. Diette,et al.  Caloric Intake in Medical ICU Patients: Consistency of Care With Guidelines and Relationship to Clinical Outcomes. , 2004, Nutrition in clinical practice : official publication of the American Society for Parenteral and Enteral Nutrition.

[30]  C. Hann,et al.  Rethinking glycaemic control in critical illness--from concept to clinical practice change. , 2006, Critical care and resuscitation : journal of the Australasian Academy of Critical Care Medicine.

[31]  J. Vincent,et al.  The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure , 1996, Intensive Care Medicine.

[32]  M Schetz,et al.  Intensive insulin therapy in critically ill patients. , 2001, The New England journal of medicine.

[33]  Esko Ruokonen,et al.  Sepsis and organ system failure are major determinants of post-intensive care unit mortality. , 2008, Journal of critical care.

[34]  Christopher E. Hann,et al.  Stochastic modelling of insulin sensitivity variability in critical care , 2006, Biomed. Signal Process. Control..

[35]  J. Vincent.  Organ dysfunction in patients with severe sepsis. , 2006, Surgical infections.

[36]  M. Hynninen,et al.  Accuracy of Sequential Organ Failure Assessment (SOFA) scoring in clinical practice , 2009, Acta anaesthesiologica Scandinavica.

[37]  Stephane Heritier,et al.  Intensive versus conventional glucose control in critically ill patients. , 2009, The New England journal of medicine.

[38]  J Geoffrey Chase,et al.  Model-based insulin and nutrition administration for tight glycaemic control in critical care. , 2007, Current drug delivery.

[39]  Dominic S. Lee,et al.  Implementation and evaluation of the SPRINT protocol for tight glycaemic control in critically ill patients: a clinical practice change , 2008, Critical care.

[40]  Thomas Desaive,et al.  What Makes Tight Glycemic Control ( TGC ) Tight ? The impact of variability and nutrition in 2 clinical studies , 2011 .

[41]  P. Marik,et al.  Original ResearchCritical Care MedicineToward Understanding Tight Glycemic Control in the ICU: A Systematic Review and Metaanalysis , 2010 .

[42]  G. Mcgwin,et al.  Agreement between prehospital and emergency department glasgow coma scores. , 2007, The Journal of trauma.

[43]  M. Ratner.  The Year in Review , 1990, Bio/Technology.

[44]  Michael Quintel,et al.  The impact of the severity of sepsis on the risk of hypoglycaemia and glycaemic variability , 2008, Critical care.

[45]  P. Dark,et al.  Can a score derived from the Critical Care Minimum Data Set be used as a marker of organ dysfunction? – a pilot study , 2009, BMC Research Notes.

[46]  James D Dziura,et al.  Implementation of a safe and effective insulin infusion protocol in a medical intensive care unit. , 2004, Diabetes care.

[47]  James Stephen Krinsley,et al.  Effect of an intensive glucose management protocol on the mortality of critically ill adult patients. , 2004, Mayo Clinic proceedings.

[48]  J Geoffrey Chase,et al.  Targeted glycemic reduction in critical care using closed-loop control. , 2005, Diabetes technology & therapeutics.

[49]  Lewis Rubinson,et al.  Low caloric intake is associated with nosocomial bloodstream infections in patients in the medical intensive care unit* , 2004, Critical care medicine.

[50]  Ilse Vanhorebeek,et al.  The Role of Insulin Therapy in Critically I11 Patients , 2005, Treatments in endocrinology.

[51]  C. Sprung,et al.  Use of the SOFA score to assess the incidence of organ dysfunction/failure in intensive care units: results of a multicenter, prospective study. Working group on "sepsis-related problems" of the European Society of Intensive Care Medicine. , 1998, Critical care medicine.

[52]  Rinaldo Bellomo,et al.  The impact of early hypoglycemia and blood glucose variability on outcome in critical illness , 2009, Critical care.

[53]  Thomas Lotz,et al.  A simple insulin-nutrition protocol for tight glycemic control in critical illness: development and protocol comparison. , 2006, Diabetes technology & therapeutics.

[54]  James Stephen Krinsley,et al.  Association between hyperglycemia and increased hospital mortality in a heterogeneous population of critically ill patients. , 2003, Mayo Clinic proceedings.

[55]  C. Doig,et al.  SOFA is superior to MOD score for the determination of non-neurologic organ dysfunction in patients with severe traumatic brain injury: a cohort study , 2006, Critical care.

[56]  D. Hellawell,et al.  Simple assessment of outcome after acute brain injury using the Glasgow Outcome Scale. , 2000, Scandinavian journal of rehabilitation medicine.

[57]  Johan Groeneveld,et al.  A prospective randomised multi-centre controlled trial on tight glucose control by intensive insulin therapy in adult intensive care units: the Glucontrol study , 2009, Intensive Care Medicine.

[58]  J. Vincent,et al.  Serial evaluation of the SOFA score to predict outcome in critically ill patients. , 2001, JAMA.

[59]  J. Geoffrey Chase,et al.  What Makes Tight Glycemic Control Tight? The Impact of Variability and Nutrition in Two Clinical Studies , 2010, Journal of diabetes science and technology.

[60]  F. Cerra,et al.  Applied nutrition in ICU patients. A consensus statement of the American College of Chest Physicians. , 1997, Chest.

[61]  G. Van den Berghe,et al.  Effect of insulin therapy on coagulation and fibrinolysis in medical intensive care patients* , 2008, Critical care medicine.